AV Therapeutics
New York, US
Founders & leadership
AM
Abraham MittelmanChief Executive Officer, Chairman
JG
Jan GeliebterSecretary
RK
Raj Kumar TiwariChief Scientific Officer
RP
Robert PollockChief Operating Officer, President
MC
Morton ColemanVice President
BD
Banerjee DebabrataChief Development Officer
Reported raises · per SEC filings
Form D private placements$1.3M disclosed across 1 round · 2013
▶$1.3MraisedMay 2014 · 9 investors · PharmaceuticalsRule 506(b)
▶$1.3MraisedMay 2014 · 9 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Robert PollockExecutive Officer
- Morton ColemanExecutive Officer
- Abraham MittelmanExecutive Officer, Director
- Jan GeliebterExecutive Officer
- Raj Kumar TiwariExecutive Officer, Director
- Banerjee DebabrataExecutive Officer
- Offering amount
- $3.5M
- Amount sold
- $1.3M
- Sales commissions
- $20K
- Proceeds to insiders
- $95K
- Placement agents
- Objective Equity, LLC, Palladium Capital Advisors, LLC
- First sale
- Dec 2013
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded AV Therapeutics?
- AV Therapeutics was founded by Abraham Mittelman, Jan Geliebter, Raj Kumar Tiwari.
- How much funding has AV Therapeutics raised?
- AV Therapeutics has disclosed $1.3M raised across 1 round.
- Where is AV Therapeutics headquartered?
- AV Therapeutics is headquartered in New York, US.